STXBP1 rs886043572: Understanding Pathogenic Variants
The rs886043572 variant is a rare genetic change located within the STXBP1 gene. It is classified as a pathogenic mutation associated with early infantile epileptic encephalopathy, a condition characterized by recurrent seizures and developmental delays.
What each genotype means
Typical STXBP1 function
This genotype represents the common, non-variant sequence for this position in the STXBP1 gene. It is not associated with the pathogenic effects described for the variant, and individuals with this genotype do not carry the specific mutation linked to early infantile epileptic encephalopathy 9.
This is the most common genotype found in the general population.
Pathogenic variant carrier
This genotype indicates the presence of the c.1651C>T (p.Arg551Cys) mutation, which is classified as pathogenic. Research indicates this variant disrupts the STXBP1 protein, and it is strongly associated with early infantile epileptic encephalopathy 9. Please discuss these findings with a medical geneticist or your clinician to understand the clinical implications for your specific health context.
This variant is extremely rare and is typically identified as a de novo mutation, meaning it is generally not inherited from parents.
Pathogenic variant homozygous
This genotype indicates that both copies of the gene carry the c.1651C>T mutation. Given the severe nature of STXBP1-related encephalopathy, this finding is clinically significant and requires professional medical evaluation. Please consult with a specialist to discuss the implications of this result.
This genotype is not observed in standard population databases and is considered exceptionally rare.
Understanding the STXBP1 Gene
The STXBP1 gene provides instructions for making a protein called syntaxin-binding protein 1, also known as Munc18-1. This protein plays a critical role in the nervous system by regulating the release of neurotransmitters, which are chemicals that allow neurons to communicate with one another. By facilitating the docking and fusion of synaptic vesicles at the neuron's membrane, STXBP1 ensures that signals are transmitted correctly across synapses. When the STXBP1 gene is mutated, the resulting protein may be unstable, reduced in quantity, or functionally impaired. This disruption in neurotransmitter release can lead to an imbalance in neuronal activity, often resulting in the uncontrolled excitation of neurons that manifests as seizures. Because this protein is essential for normal brain function, mutations in this gene are frequently linked to severe neurodevelopmental disorders.
The Nature of the rs886043572 Variant
The variant rs886043572 is a specific alteration within the STXBP1 gene sequence. In the context of clinical genetics, this variant is identified as pathogenic, meaning it is known to disrupt the normal function of the STXBP1 protein. Research into STXBP1-related conditions indicates that pathogenic variants can occur throughout the gene's domains, leading to either haploinsufficiency—where the body produces insufficient functional protein—or dominant-negative effects, where the abnormal protein interferes with the function of the normal copy. Because this variant is associated with early infantile epileptic encephalopathy, it is considered a high-attention finding in clinical settings. It is important to note that while the association with epilepsy is established, the specific clinical severity can vary between individuals, and researchers continue to study how different mutations impact the overall clinical spectrum of STXBP1-related disorders.
Research and Clinical Evidence
Current scientific literature, including studies published in journals like CNS Neuroscience & Therapeutics and various clinical databases, highlights STXBP1 as a major gene associated with developmental and epileptic encephalopathy (DEE). Evidence for variants like rs886043572 is derived from clinical sequencing of patients presenting with neonatal or infantile-onset seizures. While the link between STXBP1 mutations and epilepsy is well-documented, the evidence strength for specific rare variants can be limited by the small number of reported cases. Ongoing research, including the development of machine learning models like EpiPred, aims to better classify these variants and predict their functional impact on protein stability and interaction. Because many STXBP1 variants are rare, clinicians often rely on a combination of genetic testing, functional assays, and clinical observation to understand the implications of a specific genotype for an individual patient.
Population Frequency and Clinical Context
The rs886043572 variant is classified as rare in the general population. In clinical genetics, rare variants are typically identified through targeted gene panel sequencing or whole-exome sequencing in individuals undergoing evaluation for unexplained epilepsy or developmental delay. Because the variant is not common in the general population, it is not typically found in routine health screenings. If a genetic test identifies this variant, it is essential to consult with a medical geneticist or a neurologist who specializes in epilepsy. These professionals can provide context regarding the variant's significance, discuss the potential for clinical symptoms, and offer guidance on management strategies. There is currently no specific disease-modifying therapy for STXBP1-related conditions, so clinical management focuses on the treatment of seizures and supportive care for developmental needs.
What This Information Means for You
Genetic information regarding pathogenic variants like rs886043572 is complex and should always be interpreted by a qualified healthcare provider. If you or a family member have received a report identifying this variant, it is important to understand that this is not a diagnosis in itself, but a piece of information that requires clinical correlation. You cannot use this information to self-diagnose or determine a treatment plan. Always discuss genetic findings with a clinician or genetic counselor who can explain the results in the context of personal and family medical history. They can help determine if further testing is needed and discuss the implications for other family members. Remember that medical research is constantly evolving, and your healthcare team is the best resource for the most current and accurate information regarding your specific health situation.
How common is this variant?
The rs886043572 variant is rare in the general population, with its presence typically identified only in clinical cohorts of individuals with epilepsy.
Frequently asked questions
What is STXBP1-related epilepsy?
STXBP1-related epilepsy is a condition caused by mutations in the STXBP1 gene, leading to recurrent seizures and developmental delays. It is often classified under the umbrella of developmental and epileptic encephalopathies.
Is rs886043572 inherited?
STXBP1-related conditions are typically inherited in an autosomal dominant pattern. However, many reported cases are de novo, meaning the mutation occurred for the first time in the affected individual and was not inherited from either parent.
Can I be tested for this variant?
Yes, this variant can be identified through clinical genetic testing, such as a targeted epilepsy gene panel or whole-exome sequencing. Such testing should be ordered and interpreted by a healthcare professional.
Are there treatments for STXBP1 mutations?
There is currently no specific disease-modifying therapy for STXBP1-related disorders. Treatment is generally focused on managing seizures with anti-epileptic medications and providing supportive care for developmental needs.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs886043572?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29